Senomyx (SNMX) Tops Q3 EPS by 1c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/12/2026
- Nasdaq falls ahead of earnings, economic data while oil rallies
- Oil prices rise on Saudi Arabia attacks, overshadowing Trump's diesel deal
- Will surging equity supply derail the U.S. bull market? Goldman Sachs weighs in
- Broadcom CEO says many AI investors are gamblers
- "Not buying Chipotle": Starbucks squashes blockbuster acquisition speculation
Tweet
Share
E-mailGet Alerts SNMX Hot Sheet
Price: $1.49 --0%
Financial Fact:
Commercial revenues: 2.55M
Today's EPS Names:
SMXT, NRIX, VFS, More
Financial Fact:
Commercial revenues: 2.55M
Today's EPS Names:
SMXT, NRIX, VFS, More
Join SI Premium – FREE
Senomyx (NASDAQ: SNMX) reported Q3 EPS of ($0.05), $0.01 better than the analyst estimate of ($0.06). Revenue for the quarter came in at $7.39 million versus the consensus estimate of $7.62 million.
Senomyx sees FY2015 EPS of $0.27-$0.31, versus the consensus of ($0.30). Senomyx sees FY2015 revenue of $25-30 million, versus the consensus of $26.6 million.
For earnings history and earnings-related data on Senomyx (SNMX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nurix Therapeutics, Inc. (NRIX) Reports Q3 EPS of $4.73
- Figs shares jump after Q2 earnings review
- Nurix Therapeutics falls 2% following Q3 earnings as operating expenses up
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
